From here:
“... Deborah L. Birx will succeed Dr. Brian Varnum as the Chief Executive Officer of the Company, effective immediately. Dr. Birx will also join Armata's Board of Directors.”
Simultaneously:
“.. announced that it has entered into a credit and security agreement with Innoviva Strategic Opportunities LLC, a wholly‐owned subsidiary of Innoviva, Inc. (Nasdaq: INVA) (collectively, "Innoviva"). The gross proceeds of the credit agreement at closing are $25 million before transaction‐related expenses.
Looks like Merck had a hand in things.
Pipeline Overview - Armata Pharmaceuticals
“Armata’s therapeutic phage candidates aim to address areas of significant unmet clinical need, by targeting key antibiotic-resistant bacteria including those on the World Health Organization’s global priority pathogens list. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Proprietary synthetic phage candidates designed to target an undisclosed infectious disease agent are being developed in partnership with Merck. “
Onwards
Please upgrade to paid, or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. Coffee donations here: https://ko-fi.com/peterhalligan Buying just one Ko-Fi a week for $3 is 50 bucks more than an annual $100 subscription!
Did you see Del Bigtrees interview with Scott Atlas? Atlas calls Deb and Tony “low level thinkers” who couldn’t even qualify for a position in Atlass university department. Deb never brought data or studies to meetings to justify her Karen crazy directives and she thought Atlas was crazy for actually following science. Low level thinkers control our government. And all the low level thinker citizens are begging for more.
These freakin’ scumbags…. I can’t say the quiet part out loud. God help us.